EMA — authorised 19 September 2019
- Marketing authorisation holder: GW Pharma (International) B.V.
- Status: approved
🇪🇺 Epidiolex in European Union
EMA authorised Epidiolex on 19 September 2019
Marketing authorisation
Epidiolex in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Epidiolex approved in European Union?
Yes. EMA authorised it on 19 September 2019.
Who is the marketing authorisation holder for Epidiolex in European Union?
GW Pharma (International) B.V. holds the EU marketing authorisation.